论文部分内容阅读
目的:观察参仙升脉口服液治疗缓慢性心律失常的临床疗效。方法:160例缓慢性心律失常患者随机分为两组。治疗组80例:口服参仙升脉口服液,每次20mL,每日2次;对照组80例:口服心宝丸,每次4粒,每日2次,两组均4周为1个疗程。服药前及1个疗程后均行24小时动态心电图检查,并观察疗效及不良反应。结果:治疗组临床症状改善优于对照组,24小时心电图改善情况优于对照组(P<0.05),两组均有较少不良反应。结论:参仙升脉口服液是治疗高海拔地区缓慢性心律失常安全而有效的药物。
Objective: To observe the clinical efficacy of Shenxian Shengmai Oral Liquid in the treatment of bradyarrhythmia. Methods: 160 patients with bradyarrhythmia were randomly divided into two groups. Treatment group of 80 patients: oral Shenxian Shengmai oral solution, each 20mL, 2 times a day; control group of 80 patients: oral heart treasure pills, 4 capsules twice daily, two groups were 4 weeks for a Course of treatment. Before taking a course of treatment and a 24-hour Holter examination, and observe the efficacy and adverse reactions. Results: The improvement of clinical symptoms in the treatment group was better than that in the control group. The improvement of 24-hour ECG was better than that of the control group (P <0.05). Both groups had fewer adverse reactions. Conclusion: Shenxian Shengmai Oral Liquid is safe and effective in treating chronic arrhythmia in high altitude areas.